- Product range covers gastroenterology, women’s and men’s health, dermatology, orthopedics, respiratory, and general well-being.
- Augmented to 24 SKUs in B2C from six existing products earlier in the B2B segment.
Pune, 8 August, 2024: SAVA Healthcare’s herbal division, SAVA Herbals, has recently unveiled 30 SKUs, marking a significant expansion of its product portfolio. With a strategic move from B2B to B2C, SAVA Herbals aims to become a major player in the herbal pharmaceutical industry by aggressively promoting its diverse range of products directly to consumers.
SAVA Herbals, which has been rebranded with a fresh look, comes with an extensive product range covering gastroenterology, women’s and men’s health, dermatology, orthopedics, respiratory, and general well-being. These innovative and evidence-based products, developed to meet the growing demand in the herbal segment, are designed to benefit both Ayurvedic Physicians and customers alike.
Underscoring the business expansion, Aniruddha Rajurkar, CEO, SAVA Healthcare Limited, said, “With our diverse range of products now available directly to consumers, we are committed to enhancing patient well-being and providing quality care. To capture this growing market, we have implemented a comprehensive marketing strategy that includes ethical promotion to doctors, OTC offline promotions through ATL, BTL activities, and influencer marketing. Initially starting with six products in the B2B segment, SAVA Herbals has now expanded its portfolio to 30 products in total.”
The expansion of SAVA Herbals products is timely, as the Indian herbal products market is experiencing substantial growth. Valued at approximately INR 748.5 billion in 2023, the market is expected to grow at 17% CAGR during 2024 and 2032, according to the India Ayurvedic Products Market Report. This surge is driven by increased awareness of the benefits of natural and organic products.
Urban centers like Mumbai, Delhi, and Bengaluru are leading in the adoption of herbal wellness products due to better accessibility, higher disposable incomes, and greater health awareness. While rural areas are also growing, aided by government initiatives promoting Ayurveda and improved distribution channels.
The Ministry of AYUSH has praised the government’s efforts in promoting AYUSH and emphasized the importance of demonstrating the clinical benefits of these therapies, further validating SAVA Herbals’ commitment to quality and innovation.
Additionally, SAVA Herbals is in the process of developing new formulations aimed at treating chronic diseases. These new products will undergo clinical trials at well-recognized Ayurvedic Medical Colleges, ensuring they meet the highest standards of credibility and effectiveness. As the brand continues to innovate and expand, it remains dedicated to its mission of improving patient well-being and promoting a healthier lifestyle through the power of Ayurveda.
About SAVA Healthcare:
SAVA Healthcare Limited, headquartered in India, operates a Health Canada and PIC/s certified manufacturing facility in Gujarat, alongside an advanced R&D centre in Pune. The company is organized into four key sectors: International Business, Contract Research & Manufacturing Services (CRAMS), Companion Animal (CA) Healthcare, and Farm Animal (FA) Healthcare, as well as a specialized division, SAVA Herbals. Its International Business division extends SAVA’s reach globally, distributing both human and veterinary pharmaceuticals across North America, Central America, Asia, Africa, and the CIS countries.
Renowned for its expertise in Nasal Drug Delivery Platforms, SAVA’s CRAMS division has established itself as a reliable partner, catering to a diverse clientele of Indian and international companies. This commitment to quality and innovation positions SAVA Healthcare as a prominent player in the pharmaceutical industry.
For more information visit:
For further queries, contact:
Name: Neha Rai | Email: neha.rai@savaglobal.com | Mobile: +91 99879 22230